The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Theoretical Study of Cisplatin Binding to Purine Bases: Why Does Cisplatin Prefer Guanine over Adenine?
Abstract
The thermodynamics and kinetics for the monofunctional binding of the antitumor drug cisplatin, cis-diamminedichloroplatinum(II), to a purine base site of DNA were studied computationally using guanine and adenine as model reactants. A dominating preference for initial attack at the N7-position of guanine is established experimentally, which is a crucial first step for the formation of a 1,2-intrastrand cross-link of adjacent guanine bases that leads to bending and unwinding of DNA. These structural distortions are proposed ultimately to be responsible for the anticancer activity of cisplatin. Utilizing density functional theory in combination with a continuum solvation model, we developed a concept for the initial Pt-N7 bond formation to atomic detail. In good agreement with experiments that suggested DeltaG++ = approximately 23 kcal/mol for the monofunctional platination of guanine, our model gives DeltaG++ = 24.6 kcal/mol for guanine, whereas 30.2 kcal/mol is computed when adenine is used. This result predicts that guanine is 3-4 orders of magnitude more reactive toward cisplatin than adenine. A detailed energy decomposition and molecular orbital analysis was conducted to explain the different barrier heights. Two effects are equally important to give the preference for guanine over adenine: First, the transition state is characterized by a strong hydrogen bond between the ammine-hydrogen of cisplatin and the O=C6 moiety of guanine in addition to a stronger electrostatic interaction between the two reacting fragments. When adenine binds, only a weak hydrogen bond forms between the chloride ligand of cisplatin and the H(2)N-C6 group of adenine. Second, a significantly stronger molecular orbital interaction is identified for guanine compared to adenine. A detailed MO analysis is presented to provide an intuitive view into the different electronic features governing the character of the Pt-N7 bond in platinated purine bases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Density-functional thermochemistry. III. The role of exact exchange
Becke, A. D. (1993) · The Journal of Chemical Physics · doi:10.1063/1.464913 · Cited by 103,767
Lee, C., Yang, W., & Parr, R. G. (1988) · Physical Review B · doi:10.1103/physrevb.37.785 · Cited by 100,874
Density-functional exchange-energy approximation with correct asymptotic behavior
Becke, A. D. (1988) · Physical Review A · doi:10.1103/physreva.38.3098 · Cited by 53,711
Dunning, T. H. (1989) · The Journal of Chemical Physics · doi:10.1063/1.456153 · Cited by 31,648
Hay, P. J., & Wadt, W. R. (1985) · The Journal of Chemical Physics · doi:10.1063/1.448975 · Cited by 15,577
Hay, P. J., & Wadt, W. R. (1985) · The Journal of Chemical Physics · doi:10.1063/1.448799 · Cited by 13,824
Density-functional theory of atoms and molecules
Patterson, J. D. (1989) · Annals of Nuclear Energy · doi:10.1016/0306-4549(89)90016-9 · Cited by 12,545
te Velde, G., Bickelhaupt, F. M., Baerends, E. J., Fonseca Guerra, C., van Gisbergen, S. J. A., Snijders, J. G., & Ziegler, T. (2001) · Journal of Computational Chemistry · doi:10.1002/jcc.1056 · Cited by 10,152
Wadt, W. R., & Hay, P. J. (1985) · The Journal of Chemical Physics · doi:10.1063/1.448800 · Cited by 10,098
Tomasi, J., & Persico, M. (1994) · Chemical Reviews · doi:10.1021/cr00031a013 · Cited by 5,503
Relativistic regular two-component Hamiltonians
Lenthe, E. V., Baerends, E. J., & Snijders, J. G. (1993) · The Journal of Chemical Physics · doi:10.1063/1.466059 · Cited by 4,385
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
Self-citationOn the calculation of bonding energies by the Hartree Fock Slater method
Ziegler, T., & Rauk, A. (1977) · Theoretical Chemistry Accounts · doi:10.1007/bf00551648 · Cited by 2,541
Approximate density functional theory as a practical tool in molecular energetics and dynamics
Ziegler, T. (1991) · Chemical Reviews · doi:10.1021/cr00005a001 · Cited by 2,362
Implicit Solvation Models: Equilibria, Structure, Spectra, and Dynamics
Cramer, C. J., & Truhlar, D. G. (1999) · Chemical Reviews · doi:10.1021/cr960149m · Cited by 2,308
Current Status of Transition-State Theory
Truhlar, D. G., Garrett, B. C., & Klippenstein, S. J. (1996) · The Journal of Physical Chemistry · doi:10.1021/jp953748q · Cited by 2,279
Combining Synchronous Transit and Quasi‐Newton Methods to Find Transition States
Peng, C., & Bernhard Schlegel, H. (1993) · Israel Journal of Chemistry · doi:10.1002/ijch.199300051 · Cited by 2,076
Current Status of Platinum-Based Antitumor Drugs
Wong, E., & Giandomenico, C. M. (1999) · Chemical Reviews · doi:10.1021/cr980420v · Cited by 1,800
The Nature of the Bonding in Transition-Metal Compounds
Frenking, G., & Fröhlich, N. (2000) · Chemical Reviews · doi:10.1021/cr980401l · Cited by 1,230
Ziegler, T., & Rauk, A. (1979) · Inorganic Chemistry · doi:10.1021/ic50196a034 · Cited by 1,182
Relativistic regular two-component Hamiltonians
van Lenthe, E., van Leeuwen, R., Baerends, E. J., & Snijders, J. G. (1996) · International Journal of Quantum Chemistry · doi:10.1002/(sici)1097-461x(1996)57:3<281::aid-qua2>3.0.co;2-u · Cited by 1,145
Ziegler, T., & Rauk, A. (1979) · Inorganic Chemistry · doi:10.1021/ic50197a006 · Cited by 1,043
Tannor, D. J., Marten, B., Murphy, R., Friesner, R. A., Sitkoff, D., Nicholls, A., Honig, B., Ringnalda, M., & Goddard, W. A. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00105a030 · Cited by 1,043
Self-citationFichtinger-Schepman, A. M. J., Van der Veer, J. L., Den Hartog, J. H. J., Lohman, P. H. M., & Reedijk, J. (1985) · Biochemistry · doi:10.1021/bi00324a025 · Cited by 1,024
Marten, B., Kim, K., Cortis, C., Friesner, R. A., Murphy, R. B., Ringnalda, M. N., Sitkoff, D., & Honig, B. (1996) · The Journal of Physical Chemistry · doi:10.1021/jp953087x · Cited by 952
Self-citationStructural aspects of platinum anticancer drug interactions with DNA
Sherman, S. E., & Lippard, S. J. (1987) · Chemical Reviews · doi:10.1021/cr00081a013 · Cited by 930
Self-citationNon-Platinum Chemotherapeutic Metallopharmaceuticals
Clarke, M. J., Zhu, F., & Frasca, D. R. (1999) · Chemical Reviews · doi:10.1021/cr9804238 · Cited by 908
Fuertes, M. A., Alonso, C., & Pérez, J. M. (2003) · Chemical Reviews · doi:10.1021/cr020010d · Cited by 893
Oxaliplatin: A review of preclinical and clinical studies
Raymond, E., Chaney, S. G., Taamma, A., & Cvitkovic, E. (1998) · Annals of Oncology · doi:10.1023/a:1008213732429 · Cited by 643
New clues for platinum antitumor chemistry: Kinetically controlled metal binding to DNA
Reedijk, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737293100 · Cited by 617
Bancroft, D. P., Lepre, C. A., & Lippard, S. J. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00175a020 · Cited by 477
Self-citationReevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA
Eastman, A. (1986) · Biochemistry · doi:10.1021/bi00361a026 · Cited by 458
New Cisplatin Analogues in Development: A Review
Weiss, R. B., & Christian, M. C. (1993) · Drugs · doi:10.2165/00003495-199346030-00003 · Cited by 404
Clinical Perspectives on Platinum Resistance
Giaccone, G. (2000) · Drugs · doi:10.2165/00003495-200059004-00002 · Cited by 364
Hydrolysis Theory for Cisplatin and Its Analogues Based on Density Functional Studies
Zhang, Y., Guo, Z., & You, X.-Z. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0023938 · Cited by 317
Preclinical Perspectives on Platinum Resistance
Kelland, L. R. (2000) · Drugs · doi:10.2165/00003495-200059004-00001 · Cited by 280
The mechanism of action of platinum antitumor drugs
Reedijk, J. (1987) · Pure and Applied Chemistry · doi:10.1351/pac198759020181 · Cited by 277
The relevance of hydrogen bonding in the mechanism of action of platinum antitumor compounds
Reedijk, J. (1992) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)92433-2 · Cited by 247
Spingler, B., Whittington, D. A., & Lippard, S. J. (2001) · Inorganic Chemistry · doi:10.1021/ic010790t · Cited by 207
Self-citationCarloni, P., Sprik, M., & Andreoni, W. (2000) · The Journal of Physical Chemistry B · doi:10.1021/jp992590x · Cited by 161
Amide-Water and Amide-Amide Hydrogen Bond Strengths
Dixon, D. A., Dobbs, K. D., & Valentini, J. J. (1994) · The Journal of Physical Chemistry · doi:10.1021/j100102a001 · Cited by 161
Šponer, J., Šponer, J. E., Gorb, L., et al. (1999) · The Journal of Physical Chemistry A · doi:10.1021/jp992337x · Cited by 149
Current and future potential roles of the platinum drugs in the treatment of ovarian cancer
Piccart, M. J., Lamb, H., & Vermorken, J. B. (2001) · Annals of Oncology · doi:10.1023/a:1012259625746 · Cited by 137
Theoretical Modeling of Water Exchange on [Pd(H2O)4]2+, [Pt(H2O)4]2+, and trans-[PtCl2(H2O)2]
Deeth, R. J., & Elding, L. I. (1996) · Inorganic Chemistry · doi:10.1021/ic950335v · Cited by 122
New Developments and Approaches in the Platinum Arena
Judson, I. R., & Kèlland, L. R. (2000) · Drugs · doi:10.2165/00003495-200059004-00004 · Cited by 121
Structure and Reactivity in Aqueous Solution
Cramer, C. J., & Truhlar, D. G. (1994) · ACS symposium series · doi:10.1021/bk-1994-0568 · Cited by 110
Mello, J. A., Lippard, S. J., & Essigmann, J. M. (1995) · Biochemistry · doi:10.1021/bi00045a020 · Cited by 101
Self-citationBaik, M., Friesner, R. A., & Lippard, S. J. (2002) · Journal of the American Chemical Society · doi:10.1021/ja017588+ · Cited by 91
Self-citationDeubel, D. V. (2002) · Journal of the American Chemical Society · doi:10.1021/ja012221q · Cited by 90
Teuben, J., Bauer, C., Wang, A. H. ‐., & Reedijk, J. (1999) · Biochemistry · doi:10.1021/bi9904757 · Cited by 79
Platinum-Modified Nucleobase Pairs in the Solid State: A Theoretical Study
Carloni, P., & Andreoni, W. (1996) · The Journal of Physical Chemistry · doi:10.1021/jp961738z · Cited by 53
Binding of Pt(NH3)32+ to nucleic acid bases
Basch, H. I., Krauß, M., Stevens, W., & Cohen, D. (1986) · Inorganic Chemistry · doi:10.1021/ic00225a019 · Cited by 41
Ab Initio Investigation of Ethane Dissociation Using Generalized Transition State Theory
Lorant, F., Béhar, F., Goddard, W. A., & Tang, Y. (2001) · The Journal of Physical Chemistry A · doi:10.1021/jp004094a · Cited by 33
Carboplatin versus cisplatin: density functional approach to their molecular properties
Tornaghi, E., Andreoni, W., Carloni, P., Hutter, J., & Parrinello, M. (1995) · Chemical Physics Letters · doi:10.1016/0009-2614(95)01099-2 · Cited by 29
Cited by
Cisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751
Zhou, W., Saran, R., & Liu, J. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00063 · Cited by 931
Using coordination chemistry to design new medicines
Ronconi, L., & Sadler, P. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2006.11.017 · Cited by 608
Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy
Tchounwou, P. B., Dasari, S., Noubissi, F. K., Ray, P., & Kumar, S. (2021) · Journal of Experimental Pharmacology · doi:10.2147/jep.s267383 · Cited by 384
Metadata
- Authors
- Baik, M.-H., Friesner, R. A., & Lippard, S. J.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2003-10-28
- Volume
- 125
- Issue
- 46
- Pages
- 14082-14092
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2017681697
- Cited by
- 293
- References
- 56
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.